Results 291 to 300 of about 14,297,124 (313)

ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences

Cell, 2017
Andreas Linkermann, Cliff Guy, Douglas R. Green   +2 more
exaly  

Ligand field effect for Dysprosium(III) and Lutetium(III) adsorption and EXAFS coordination with novel composite nanomaterials

Chemical Engineering Journal, 2017
Mohammad Rezaul Karim, Md. Munjur Hasan, Md. Rabiul Awual   +2 more
exaly  

Buildup of III-V-compound semiconductor heterojunctions: Structural and electronic properties of monolayer-thick III-V overlayers on III-V substrates

Physical Review B, 1989
, Moison, , Guille, , Van Rompay M, , Barthe, , Houzay, , Bensoussan   +5 more
openaire   +2 more sources

Study Finds Up to Half of Phase III Clinical Trials Successful

Ca-A Cancer Journal for Clinicians, 2008
exaly  

Methods for growing III-V materials on a non III-V material substrate

2014
BUGGE RENATO, MYRVAGNES GEIR, NILSEN TRON ARNE   +2 more
openaire   +2 more sources

Part III: Financial aspects of a hospital cancer registry

Ca-A Cancer Journal for Clinicians, 1964
exaly  

III–V (GaAs)

1995
openaire   +1 more source

Twenty-year results of the randomized European Organization for Research and Treatment of Cancer trial 22922/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancer.

Ca-A Cancer Journal for Clinicians
Adinda Baten, Philip Poortmans, Caroline Weltens   +2 more
exaly  

III–V Semiconductors

1980
openaire   +1 more source

Cantos III-V

Jane Stabler, Gavin Hopps
openaire   +1 more source